SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-013720
Filing Date
2019-04-29
Accepted
2019-04-29 16:11:38
Documents
65
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q crsp-10q_20190331.htm 10-Q 1167597
2 EX-31.1 crsp-ex311_8.htm EX-31.1 19186
3 EX-31.2 crsp-ex312_7.htm EX-31.2 19441
4 EX-32.1 crsp-ex321_12.htm EX-32.1 7757
  Complete submission text file 0001564590-19-013720.txt   4977038

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT crsp-20190331.xml EX-101.INS 998232
6 XBRL TAXONOMY EXTENSION SCHEMA crsp-20190331.xsd EX-101.SCH 47342
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE crsp-20190331_cal.xml EX-101.CAL 44065
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE crsp-20190331_def.xml EX-101.DEF 131102
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE crsp-20190331_lab.xml EX-101.LAB 366513
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE crsp-20190331_pre.xml EX-101.PRE 278893
Mailing Address BAARERSTRASSE 14 ZUG V8 CH-6300
Business Address BAARERSTRASSE 14 ZUG V8 CH-6300 6173154600
CRISPR Therapeutics AG (Filer) CIK: 0001674416 (see all company filings)

IRS No.: 473173478 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37923 | Film No.: 19776018
SIC: 2836 Biological Products, (No Diagnostic Substances)